Whisone AnalystInvestor workspace
NEIMETHHealthcareUpdated 2h ago

NEIMETH

NEIMETH (NEIMETH) is listed on the Nigerian Exchange in the Healthcare sector, with exposure to Pharmaceutical Preparations. This page brings together the current share price, valuation, dividend context, business summary, and a practical 12-week outlook so you can assess the stock faster.

Sector

Healthcare

Market cap

₦39.5B

Dividend yield

N/A

P/E ratio

40.48

Current price

₦9.25

Updated Updated 2h ago

Wait (12-week)

12-week outlook signal

Research score60/100

P/B

15.04

RSI

43.71

52W high

₦16.15

52W low

₦2.60

Valuation view

Priced richer than peers

Income view

Income signal not strong yet

Momentum view

Momentum is balanced

Risk view

Moderate volatility profile

Business trend

Latest operating data is available

Neimeth is a Nigerian pharmaceutical company that makes and sells medicines and other health products. It earns money by selling those products to hospitals, pharmacies, wholesalers and through distribution partners.

Investors usually follow NEIMETH for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.

Why this stock stands out

What looks attractive right now.

Return on equity is healthy at roughly 37.1%, which suggests the business is using shareholder capital well.

Latest revenue

₦7.37B

Most recent reported period.

Latest net profit

₦976M

Most recent reported period.

ROE

37.1%

Return on equity

Debt / equity

3.66

Lower is usually safer.

P/B ratio

15.04

Useful for book value support.

Explain the key numbers

P/E ratio

40.48

Price-to-earnings shows what investors pay for every ₦1 of profit. Lower can signal cheaper valuation, but only if profits are reliable.

Compare P/E with peers in the same sector to avoid false signals.

₦0.07

2022-03-15

Payment: 2022-03-25 · Qualification: 2022-03-14

₦0.07

2021-02-23

Payment: 2021-03-12 · Qualification: 2021-02-22

Watch the latest corporate action: Estimated earnings date.
Fundamentals were last updated 0 day(s) ago, so the next filing matters.
Monitor leverage discipline. Debt-to-equity is currently about 3.66x.

Estimated earnings date

2026-04-28

Estimated earnings date

2026-03-25

Price and session

Current price
₦9.25?
Open
₦9.25?
Previous close
₦9.00?
Day range
₦9.25 – ₦9.25?
52-week range
₦2.60 – ₦16.15?

Volume & liquidity

Today volume
833,143?
Average volume
1,826,852?
Volume vs average
0.46x?
Avg turnover/day
N/A
Tradeability
Hard to exit

Valuation

Market cap
₦39.5B?
P/E
40.48?
Forward P/E
N/A?
P/B
15.04?
Book value/share
0.62?

Momentum

Beta
0.85?
RSI
43.71?

Income & dividend

EPS
0.23?
Dividend yield
N/A?
Dividend/share
₦0.07?
Ex-dividend date
2022-03-14?
Dividend records
2?

Latest financials

Revenue
₦7.37B?
Operating profit
₦2.17B?
Net income
₦976M
Operating cash flow
₦1.51B?
Capex
-₦278.23?

Event data

Estimated earnings date
2026-04-28

NEIMETH

NEIMETH

Price: ₦9.25

P/E: 40.48

Yield: N/A

AUSTINLAZ

AUSTINLAZ

Price: ₦3.73

P/E: N/A

Yield: N/A

FIDSON

FIDSON

Price: ₦99.50

P/E: 24.16

Yield: 1.51%

MAYBAKER

MAYBAKER

Price: ₦37.90

P/E: 14.74

Yield: 1.02%

Price updated

0d ago

Fundamentals updated

0d ago

Market cap

₦39.5B

Open

₦9.25

Previous close

₦9.00

Day range

₦9.25 – ₦9.25

52-week range

₦2.60 – ₦16.15

Volume

833,143

Average volume

1,826,852

Beta

0.85

RSI

43.71

Latest revenue

₦7.37B

Latest net profit

₦976M

Book value / share

0.62

TradeabilityHard to exit

Thin trading conditions can make exits difficult. Keep size modest and use limit orders.

Caution: this stock may not be easy to sell quickly.

Compare mode →AI Expert analysis →

Login to use AI Analyst.

Main risks

Debt is heavy relative to equity, with debt-to-equity around 3.66x.